19-8856110-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6BP7BS2_Supporting
The NM_001414686.1(MUC16):c.43815G>A(p.Val14605Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00227 in 1,598,218 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 10 hom. )
Consequence
MUC16
NM_001414686.1 synonymous
NM_001414686.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.77
Genes affected
MUC16 (HGNC:15582): (mucin 16, cell surface associated) This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-8856110-C-T is Benign according to our data. Variant chr19-8856110-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3035510.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.77 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 10 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC16 | NM_001414686.1 | c.43815G>A | p.Val14605Val | synonymous_variant | 91/94 | NP_001401615.1 | ||
MUC16 | NM_001401501.2 | c.43389G>A | p.Val14463Val | synonymous_variant | 90/93 | NP_001388430.1 | ||
MUC16 | NM_001414687.1 | c.43269G>A | p.Val14423Val | synonymous_variant | 87/90 | NP_001401616.1 | ||
MUC16 | NM_024690.2 | c.43167G>A | p.Val14389Val | synonymous_variant | 81/84 | NP_078966.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC16 | ENST00000710609.1 | c.43287G>A | p.Val14429Val | synonymous_variant | 84/87 | ENSP00000518375.1 | ||||
MUC16 | ENST00000397910.8 | c.43167G>A | p.Val14389Val | synonymous_variant | 81/84 | 5 | ENSP00000381008.2 | |||
MUC16 | ENST00000710610.1 | c.33993G>A | p.Val11331Val | synonymous_variant | 83/86 | ENSP00000518376.1 |
Frequencies
GnomAD3 genomes AF: 0.00139 AC: 212AN: 152202Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
212
AN:
152202
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00113 AC: 253AN: 224468Hom.: 1 AF XY: 0.00104 AC XY: 126AN XY: 120652
GnomAD3 exomes
AF:
AC:
253
AN:
224468
Hom.:
AF XY:
AC XY:
126
AN XY:
120652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00237 AC: 3423AN: 1446016Hom.: 10 Cov.: 31 AF XY: 0.00224 AC XY: 1604AN XY: 717508
GnomAD4 exome
AF:
AC:
3423
AN:
1446016
Hom.:
Cov.:
31
AF XY:
AC XY:
1604
AN XY:
717508
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00139 AC: 212AN: 152202Hom.: 1 Cov.: 33 AF XY: 0.00136 AC XY: 101AN XY: 74360
GnomAD4 genome
AF:
AC:
212
AN:
152202
Hom.:
Cov.:
33
AF XY:
AC XY:
101
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MUC16-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at